Differential cyclin D1 requirements of proliferating Schwann cells during development and after injury

Molecular and Cellular Neuroscience

Volumn 18, Issue 6, 2001, Pages 581-592

  Atanasoski, Suzana ^a   Shumas, Susan ^b   Dickson, Clive ^c   Scherer, Steven S ^b   Suter, Ueli ^a  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELL MATURATION; CELL NUCLEUS; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; IMMUNOFLUORESCENCE MICROSCOPY; IN VIVO STUDY; MOUSE; MYELINATION; NERVE INJURY; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; SCHWANN CELL; SCIATIC NERVE; WESTERN BLOTTING;

ANIMALIA;

EID: 0035687780     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1006/mcne.2001.1055     Document Type: Article

References (56)

1. Independent regulation of human D-type cyclin gene expression during G1 phase in primary human T lymphocytes
2. Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation
3. Regulation of G1/S transition by cyclins D2 and D3 in hematopoietic cells
4. Cyclin D1 is a nuclear protein required for cell cycle progression in G1
5. Cyclin D1 protein expression and function in human breast cancer
6. Cell cycle-related variation and tissue-restricted expression of human cyclin D1 protein
7. Establishment and characterization of a mouse Schwann cell line which produces myelin in vivo
8. Duration of synthesis phase in neuilemma cells in mouse sciatic nerve during degeneration
9. Cell cycle dependent expression and stability of the nuclear protein detected by Ki-67 antibody in HL-60 cells
10. Non-myelin-forming Schwann cells proliferate rapidly during Wallerian degeneration in the rat sciatic nerve
11. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization
12. A dominant-negative cyclin D1 mutant prevents nuclear import of cyclin-dependent kinase 4 (CDK4) and its phosphorylation by CDK-activating kinase
13. Physical interaction of the retinoblastoma protein with human D cyclins
14. Evaluative procedures to detect, characterize, and assess the severity of diabetic neuropathy
15. Hereditary motor and sensory neuropathies
16. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins
17. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development
18. Cyclins, cyclin-dependent kinases and differentiation
19. Hereditary motor and sensory neuropathies
20. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins
21. Schwann cells and their precursors emerge as major regulators of nerve development
22. Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer
23. Cytoplasmic localization of cyclin D3 in seminiferous tubules during testicular development
24. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4
25. Expression of cell cycle proteins (cyclin D1 and cdk4) after controlled cortical impact in rat brain
26. A developmentally regulated switch directs regenerative growth of Schwann cells through cyclin D1
27. Neuronal cdc2-like kinase
28. SSeCKS, a major protein kinase C substrate with tumor suppressor activity, regulates G(1)→S progression by controlling the expression and cellular compartmentalization of cyclin D
29. Cyclin D2 is a moderately oscillating nucleoprotein required for G1 phase progression in specific cell types
30. Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines
31. S100 is preferentially distributed in myelin-forming Schwann cells
32. Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins
33. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle
34. A family of human cdc2-related protein kinases
35. Cloning and characterization of human cyclin D3, a cDNA closely related in sequence to the PRAD1/cyclin D1 proto-oncogene
36. Connexin32 in hereditary neuropathies
37. Detection and processing of peripheral myelin protein PMP22 in cultured Schwann cells
38. Coordinate regulation of multiple histone mRNAs during the cell cycle in HeLa cells
39. Evolving ideas about cyclins
40. Studies of Schwann cell proliferation. I. An analysis in tissue culture of proliferation during development, Wallerian degeneration, and direct injury
41. Studies of Schwann cell proliferation. III. Evidence for the surface localization of the neurite mitogen
42. Studies of Schwann cell proliferation. II. Characterization of the stimulation and specificity of the response to a neurite membrane fraction
43. Axons regulate Schwann cell expression of the POU transcription factor SCIP
44. Human cyclin D1 encodes a labile nuclear protein whose synthesis is directly induced by growth factors and suppressed by cyclic AMP
45. Mammalian G1 cyclins
46. G1 phase progression: Cycling on cue
47. Cancer cell cycles
48. CDK inhibitors: Positive and negative regulators of G1-phase progression
49. Wallerian degeneration in the peripheral nervous system: Participation of both Schwann cells and macrophages in myelin degradation
50. Identification of cells expressing a D type G1 cyclin in matured brain: Implication for its role in neuronal function
51. Molecular biology of axon-glia interactions in the peripheral nervous system
52. Progesterone inhibits estrogen-induced cyclin D1 and cdk4 nuclear translocation, cyclin E- and cyclin A-cdk2 kinase activation, and cell proliferation in uterine epithelial cells in mice
53. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA
54. Differential proliferative responses of cultured Schwann cells to axolemma- and myelin-enriched fractions. I. Biochemical studies
55. CDK-independent activation of estrogen receptor by cyclin D1